Randomised phase II trial of pegylated liposomal doxorubicin (DOXILR/CAELYXR) versus doxorubicin in the treatment of advanced or metastatic sift tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group
dc.contributor.author | Judson, Ian R | |
dc.contributor.author | Radford, John A | |
dc.contributor.author | Harris, Maggie A | |
dc.contributor.author | Blay, Jean-Yves | |
dc.contributor.author | Van Hoesel, Q | |
dc.contributor.author | Le Cesne, A | |
dc.contributor.author | Van Oosterom, A | |
dc.contributor.author | Clemons, Mark | |
dc.contributor.author | Kamby, C | |
dc.contributor.author | Hermans, C | |
dc.contributor.author | Whittaker, J | |
dc.contributor.author | Donato di Paola, E | |
dc.contributor.author | Verweij, Jaap | |
dc.contributor.author | Nielsen, S | |
dc.date.accessioned | 2009-10-02T15:26:51Z | |
dc.date.available | 2009-10-02T15:26:51Z | |
dc.date.issued | 2001-05 | |
dc.identifier.citation | Randomised phase II trial of pegylated liposomal doxorubicin (DOXILR/CAELYXR) versus doxorubicin in the treatment of advanced or metastatic sift tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. 2001, 37(7) : 870-877 Eur J Cancer | en |
dc.identifier.issn | 09598049 | |
dc.identifier.doi | 10.1016/S0959-8049(01)00050-8 | |
dc.identifier.uri | http://hdl.handle.net/10541/83378 | |
dc.language.iso | en | en |
dc.subject | Soft Tissue Sarcoma | en |
dc.subject | Doxorubicin | en |
dc.subject | Liposomal Doxorubicin | en |
dc.subject | Randomized Phase II Trial | en |
dc.title | Randomised phase II trial of pegylated liposomal doxorubicin (DOXILR/CAELYXR) versus doxorubicin in the treatment of advanced or metastatic sift tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group | en |
dc.type | Article | en |
dc.contributor.department | Royal Marsden Hospital, London, UK | en |
dc.identifier.journal | European Journal of Cancer | en |